Hybrid therapy as first-line regimen for Helicobacter pylori eradication in a high clarithromycin resistance area: a prospective open-label trial

BACKGROUND: Hybrid therapy is a promising first-line regimen for Helicobacter pylori (H. pylori) eradication. We evaluated a hybrid therapy, assessing the impact of antibiotic resistance on eradication outcome. METHODS: This was a prospective study that included 155 treatment-naïve patients diagnose...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgopoulos, Sotirios D., Papastergiou, Vasilios, Martinez-Gonzalez, Beatriz, Xirouchakis, Elias, Familias, Ioannis, Sgouras, Dionysis, Mentis, Andreas, Karatapanis, Stylianos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825950/
https://www.ncbi.nlm.nih.gov/pubmed/29507467
http://dx.doi.org/10.20524/aog.2017.0221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825950/
https://www.ncbi.nlm.nih.gov/pubmed/29507467
http://dx.doi.org/10.20524/aog.2017.0221

Ejemplares similares